SHOULD WE TEST THE FIRST POLAR BODY OR THE EMBRYO
|
|
- Solomon Freeman
- 6 years ago
- Views:
Transcription
1 SHOULD WE TEST THE FIRST POLAR BODY OR THE EMBRYO L. Gianaroli, C.M. Magli, A.P. Ferraretti Reproductive Medicine Unit - Via Mazzini, Bologna sismer@sismer.it
2 WOMEN S REPRODUCTIVE HEALTH IN THE 21 st CENTURY - Increased lifespan - Decreased fertility in European population Increased maternal age Increased number of divorces Increased male infertility - Increased demand of genetic health - Increased demand of prevention of disorders ONE BABY ONE HEALTHY BABY
3 INTERNATIONAL WORKING GROUP ON PGD > cycles Aneuploidy HLA-typing Monogenic disorders Translocations Kuliev and Verlinsky: Thirteen years experience of preimplantation diagnosis: report of the Fifth International Symposium on Preimplantation Genetics. Reprod Biomed Online 8, , VISION 2000
4 Present Clinical Applications -aneuploidies -translocations -monogenic diseases -mitochondrial diseases -HLA -cancer risk -late onset diseases Risk for aneuploidy
5 INCIDENCE OF ANEUPLOIDY DURING DEVELOPMENT Most common aneuploidies % X Y ,X (10%) (50%) XXX XXY XYY Sperm Oocytes Embryos Spontaneous Stillbirths Livebirths abortions % Biochemical pregnancies a a P<0.05 Conventional cycles PGD cycles n=109 n=67 a VISION 2000
6 THE ORIGIN OF HUMAN TRISOMY Trisomy N. Cases Paternal (%) MI MII Maternal (%) MI MII Postzygotic (%) XXY XXX Hassold and Hunt (2001) Nature Reviews Genetics VISION 2000
7 BLASTOCYST DEVELOPMENT ACCORDING TO THE CHROMOSOMAL CONSTITUTION 1124 cultured embryos BLASTOCYST DEVELOPMENT n =427 NO BLASTOCYST DEVELOPMENT n =697 NORMAL 31 P <0.001 MONOSOMY TRISOMY HAPLOIDY POLYPLOIDY COMPLEX ABNORM P < NORMAL MONOSOMY TRISOMY HAPLOIDY POLYPLOIDY COMPLEX ABNORM % % Vision
8 BLASTOCYST DEVELOPMENT AFTER ONE CELL BIOPSY 112 hrs post insemination n= e FISH normal % d FISH abnormal 60 e c d b a b c a Number of cells at 62 hrs post insemination abcde P<0.001 Vision
9 EMBRYO CLEAVAGE AFTER ONE BLASTOMERE BIOPSY 88 hrs post insemination 60 % No cleavage Cleavage of <50% cells Morulas Number of cells at 62 hrs post insemination Vision
10 Pregnancy Rate according to female age PR Age (yrs) P< < > Pre Law Post Law VISION /03/04-3/05
11 Abortion Rate according to female age AR Age (yrs) P<0.05 < Pre Law Post Law VISION /03/04-3/05
12 Age distribution in the treated patients ( ) % of cycles Years < - - > VISION /03/04-3/05
13 AFTER THE LAW Egg retrieval Cryopreservation of all oocytes in OHSS risk cycles Cumulus removal 1 Polar Body FISH analysis Insemination of 3 mature oocytes Results before insemination Embryo culture Transfer of all vital embryos Vision 2000
14 CHROMOSOMAL ANALYSIS ON OOCYTES INCIDENCE OF ANEUPLOIDY IN RELATION TO MATERNAL AGE n=1130 % a b ab yrs a P<0.01 b P<0.05 Vision
15 Years,, France : mean age at motherhood,, All births,,,, First births, Calendar year
16 %,,,,,,,,,, < >= Years * * Età materna media al parto in Emilia Romagna anni
17 - - - Medie età materna popolazione generale Emilia R. Medie età materna S. Down Emilia R.
18 CHROMOSOMAL ANALYSIS ON OOCYTES FREQUENCY OF ANEUPLOIDY IN OOCYTES ACCORDING TO AGE 30 No. observations= c % 25 ab b c a a P<0.005 b P<0.05 c P< yrs VISION
19 CHROMOSOMAL ANALYSIS ON OOCYTES INCIDENCE OF ANEUPLOIDY IN RELATION TO PATIENTS CHARACTERISTICS n=1130 % ab b a a P<0.05 b P<0.25 Maternal age 38 yrs Recurrent abortions Repeated cycles Controls Vision
20 CHROMOSOMAL ANALYSIS ON OOCYTES DISTRIBUTION OF ANEUPLOIDY PER ANALYZED CHROMOSOME IN RELATION TO PATIENTS CHARACTERISTICS n=1130 Recurrent abortions P<0.05 P<0.01 P<0.05 P<0.005 P<0.005 Maternal age Repeated cycles Controls Chromosomes No. observations: Vision
21 CHROMOSOMAL ANALYSIS ON 1 st POLAR BODY Team - clinicians Team - biologists Oocyte Pick Up IVF laboratory Cytogenetic laboratory Oocyte screening 1 hour MI, GV In Vitro Maturation MII MII PB Biopsy Fixation Hybridization probes for chromosomes Insemination of Chromosomally Normal Oocytes 6 hrs after oocyte pick up Results VISION /03/04-3/05
22 CHROMOSOMAL ANALYSIS ON 1 st POLAR BODY MECHANICAL OPENING OF OOCYTE ZONA PELLUCIDA VISION 2000
23 CHROMOSOMAL ANALYSIS ON 1 st POLAR BODY 1 ST POLAR BODY BIOPSY VISION 2000
24 CHROMOSOMAL ANALYSIS ON 1 st POLAR BODY CHROMOSOMAL ANALYSIS OF 1 ST POLAR BODY VISION 2000
25 CHROMOSOMAL ANALYSIS ON 1 st POLAR BODY ICSI AFTER 1 ST POLAR BODY BIOPSY VISION 2000
26 CHROMOSOMAL ANALYSIS ON 1 st POLAR BODY No. cycles 87 No. patients 75 Age (MSD) No. previous cycles (MSD) No. oocytes 698 No. biopsied oocytes (%) 564 (81) No. diagnosed oocytes (%) 527 (93) No. oocytes normal for the chromosomes 13, 16, 18, 21, (41) No. inseminated oocytes 207 No. fertilized oocytes (%) 136 (66) No. generated embryos (%) 129 (95) No. transferred cycles (%) 66 (76) No. clinical pregnancies (%) 14 (21) No. spontaneous abortions 1 No. ectopic pregnancies 1 Implantation rate (%) 14.6 Magli MC, Ferraretti AP, Crippa A, Lappi M, Feliciani E, Gianaroli L (2005) Impact of chromosomal analysis of first polar body in immature oocytes generated by stimulated cycles. Fertil.Steril VISION /03/04-3/05
27 % CHROMOSOMAL ANALYSIS ON 1 st POLAR BODY INCIDENCE OF ANEUPLOIDY IN RELATION TO THE MATURATION STAGE 87 cycles a a a P< MII 146 MI 34 GV Maturation stage 1 hr after oocyte pick up Magli MC, Ferraretti AP, Crippa A, Lappi M, Feliciani E, Gianaroli L (2005) Impact of chromosomal analysis of first polar body in immature oocytes generated by stimulated cycles. Fertil.Steril VISION /03/04-3/05
28 CHROMOSOMAL ANALYSIS ON 1 st POLAR BODY ACCORDING TO THE MATURATION STAGE MII MI+GV In vitro matured P No. biopsied oocytes No. diagnosed oocytes (%) 366 (95) 161 (89) No. FISH normal (%) 169 (46) 49 (30) No. FISH abnormal (%) 197 (54) 112 (70) No. missing/extra chromatid (%) No. missing/extra chromosome (%) No. complex abnormalities (%) 108 (55) 38 (34) (5) 5 (4) 80 (40) 69 (62) Magli MC, Ferraretti AP, Crippa A, Lappi M, Feliciani E, Gianaroli L (2005) Impact of chromosomal analysis of first polar body in immature oocytes generated by stimulated cycles. Fertil.Steril VISION /03/04-3/05
29 CHROMOSOMAL ANALYSIS ON 1 st POLAR BODY FREQUENCY OF ANEUPLOIDY FOR THE DIFFERENT CHROMOSOMES P In vivo matured 2.5 a 3.3 b ab 3.4 ab P<0.005 In vitro matured 6.7 cd 3.9 cf 3.6 de ef ce P<0.025 d P<0.01 f P<0.05 P<0.001 P<0.05 P<0.01 Magli MC, Ferraretti AP, Crippa A, Lappi M, Feliciani E, Gianaroli L (2005) Impact of chromosomal analysis of first polar body in immature oocytes generated by stimulated cycles. Fertil.Steril VISION /03/04-3/05
30 CHROMOSOMAL ANALYSIS ON 1 st POLAR BODY OOCYTE DEVELOPMENT IN RELATION TO THE MATURATION STAGE MII MI+GV In vitro matured No. inseminated oocytes No. fertilized oocytes (%) 107 (67) 29 (62) No. generated embryos (%) 102 (95) 27 (93) No. grade I embryos (%) 60 (59) 10 (37) No. transferred embryos (%) Magli MC, Ferraretti AP, Crippa A, Lappi M, Feliciani E, Gianaroli L (2005) Impact of chromosomal analysis of first polar body in immature oocytes generated by stimulated cycles. Fertil.Steril VISION /03/04-3/05
31 OOCYTE CRYOPRESERVATION No. Thawed cycles 86 Age (MSD) No. Thawed oocytes 289 No. Survived oocytes (%) 214 (74) No. Biopsied oocytes - No. FISH normal oocytes (%) - No. Inseminated oocytes 210 No. Fertilized oocytes 164 (78) No. Embryos 143 (87) No. Transferred cycles (%) 72 (84) No. Transferred embryos 128 No. Clinical pregnancies 8 (%) per transferred cycle (11.1) (%) per thawed cycle (9.3) Implantation rate (%) (4.9) No. Abortions (83) (43) (71) 50 (86) 23 (72) 40 6 (26.1) (18.8) Vision /04-7/10/05
32 Aim of the study - To analyze the morphology of pronuclei in zygotes which were generated by oocytes diagnosed as normal by first polar body analysis. - To relate the obtained configurations to those which had been described as predictive of euploidy in a previous study, in which the chromosomal complement had been tested by embryo biopsy. VISION 20005
33 MATERIALS and METHODS Between March 2004 and November 2005: 272 patients (age years) 308 assisted cycles in combination with the screening of aneuploidy on first PB Indication to aneuploidy screening were: Maternal age 36 years 3 3 previous IVF failures 3 spontaneous abortions Vision 2000
34 MATERIALS and METHODS One hour after collection,, oocytes were denuded by Hyase and PB biopsy on MII started immediately Up to 3 chromosomally normal oocytes were selected for ICSI At 16 hours after insemination,, oocytes were checked for the presence and morphology of pronuclei, nucleoli and polar body Vision 2000
35 MATERIALS and METHODS Five patterns of Pronuclear Morphology were described according to the position and size of pronuclei A B C D E Juxtaposed centralized Juxtaposed peripheral Centralized and separated Unequal in size Fragmented Gianaroli et al. (2003) Pronuclear morphology and chromosomal condition as scoring criteria for embryo selection. Fertil Steril 80, Vision 2000
36 MATERIALS and METHODS 5 patterns of Nucleolar Morphology were described according to the position and size of nucleoli within pronuclei Gianaroli et al. (2003) Pronuclear morphology and chromosomal condition as scoring criteria for embryo selection. Fertil Steril 80, Vision 2000
37 MATERIALS and METHODS 3 patterns for the position of the second Polar Body were described in relation to the longitudinal axis of pronuclei Gianaroli et al. (2003) Pronuclear morphology and chromosomal condition as scoring criteria for embryo selection. Fertil Steril 80, Vision 2000
38 RESULTS A total of 618 pronuclear zygotes were scored Pronuclear morphology: A B C D E In singamy n=516 (83%) n=33 (5%) n=16 (3%) n=20 (3.5%) n=13 (2%) n=20 (3.5%) 4c-1 F0 (day 2) n=170 n=154 (30%) n=7 (21%) n=1 (6%) n=4 (20%) n=2 (15%) n=2 (10%) P<0.001 Vision /04-11/05
39 RESULTS A total of 618 pronuclear zygotes were scored Nucleolar morphology In singamy n=177 (29%) n=243 (39%) n=126 (21%) n=26 (4%) n=26 (4%) n=20 (3.5%) n=48 (27%) n=79 (33%) 4c-1 F0 (day 2) n=170 n=34 (27%) n=4 (15%) n=3 (11%) n=2 (10%) P<0.001 Vision /04-11/05
40 RESULTS A total of 618 pronuclear zygotes were scored Second Polar Body position: In singamy n=299 (48%) n=286 (46%) n=13 (2%) n=20 (3.5%) n=71 (24%) 4c-1 F0 (day 2) n=170 n=93 (32%) n=2 (15%) n=2 (10%) Vision /04-11/05
41 PRONUCLEAR ZYGOTE CONFIGURATIONS OOCYTES DIAGNOSED AS CHROMOSOMALLY NORMAL AFTER 1 st PB BIOPSY n=517 a b c % A1 A2 A1 A2 A3 A3 A4 A4 A2 N zygotes= a A1, A2 vs. A1, A2 P<0.001 b A1, A2 vs. A3, A3 P<0.001 c A3, A3 vs. A4, A4, A2 P<0.001 Vision
42 PRONUCLEAR ZYGOTE CONFIGURATIONS CHROMOSOMAL STATUS IN PREIMPLANTATION EMBRYOS c d e n=1198 % a b a b A1 A2 A1 A2 A3 A3 A4 A4 A2 A5 A1 A3 A5 A4 A5 N embryos a P<0.001 b P<0.005 c For chromosomally normal embryos A1, A2, A1, A2 vs. A3, A3 P<0.001; d For chromosomally normal embryos A3, A3 vs. A4, A4, A2, A5, A1, A3, A5, A4, A5 P<0.001 e For complex abnormalities A1, A2, A1, A2, A3, A3 vs. the others P<0.001 Vision
43 59 GESTATIONAL SACS OF KNOWN PRONUCLEAR ZYGOTE CONFIGURATION A1 A2 A1 A2 A3 A3 B2 B2 C5 Total 43 gestational sacs (73%) 13 gestational sacs (22%) 3 gestational sacs (5%) gestational sacs (60%) No. gestational sacs in PB patients (n=15) 4 gestational sacs (27%) 2 gestational sacs (13%) No. gestational sacs in PGD patients (n=44) gestational sacs (77%) 9 gestational sacs (21%) 1 gestational sac (2%) Vision
44 PGD - AS MATERNAL AGE 36 YEARS % b a c d a b Abnormal embryos Transferred cycles Pregnancy rate Implantation rate c d Years n = 92 n = 100 n = 168 n = 75 N cycles ab P <0.001 cd P <0.05 Gianaroli et al. Clinical value of preimplantation genetic diagnosis. Placenta 2003 VISION
45 FREQUENCY OF CHROMOSOMAL ANEUPLOIDIES ACCORDING TO MATERNAL AGE No. observations: years Gianaroli et al. Clinical value of preimplantation genetic diagnosis. Placenta P<0.01 n=2191 P<0.05 n=2155 P<0.001 n=1899 P<0.001 n=1988 P<0.001 n=2159 VISION
46 31% Complex abnormalities 3% Polyploidy 3% Haploidy 186 CHROMOSOMAL ANALYSIS ON EMBRYOS n= % Euploidy 13% Monosomy 14% Trisomy 2% Monosomy+ trisomy 123 Tris Tris Tris Tris Tris Tris (16%) potential implantation 66 Mon Mon X Vision
47 23% Complex abnormalities 3% Polyploidy 2% Haploidy CHROMOSOMAL ANALYSIS ON EMBRYOS EMBRYOS GENERATED FROM 193 PREGNANT PATIENTS pregnancies, 1237 embryos vs. non pregnant patients P<0.005 vs. non pregnant patients P< % Euploidy 11% Monosomy 15% Trisomy 1% Monosomy+ trisomy 33 Tris Tris Tris Tris Tris Tris (16%) potential implantation 14 Mon 21 5 Mon X n=5115 Gianaroli L, Magli MC, Ferraretti AP, Tabanelli C, Trengia V, Farfalli V, Cavallini G(2005) The beneficial effects of PGD for aneuploidy supports extensive clinical application. Reprod. Biomed. Online. Vision
48 INCIDENCE OF TRANSLOCATIONS NEONATAL 0.2% INFERTILE COUPLES 0.6% SEVERE MALE INFERTILITY 3.1% RECURRENT SPONTANEOUS ABORTIONS 9.2% VISION 2000
49 TRANSLOCATION CARRIERS INFERTILE COUPLES REPRODUCTIVE HISTORY Robertsonian Reciprocal No. of patients No. of patients with previous abortions (%) 10 (29) 13 (35) No. of abortions (MSD) No. of patients with severe male factor VISION /96-life
50 PGD FOR TRANSLOCATIONS Robertsonian Reciprocal No. cycles Age No. generated embryos No. diagnosed embryos FISH normal (%) 58 (25) a 38 (14) a FISH abnormal (%) 176 (75) b 224 (86) b No. transferred cycles (%) 34 (68) c 16 (31) c No. transferred embryos No. clinical pregnancies (%) 15 (44) 6 (38) No. abortions 5* 2** Implantation rate (%) (36.0) (31.8) Take-home baby rate / patient (%) (29.4) (13.5) *1 after amniocentesis, normal karyotype; 1 t(13;14) was 47XY,21; 1 t(13;14) was 47XY,22 ** unbalanced ab <0.01 c <0.001 VISION /96-life
51 PREGNANCY RATE IN RELATION TO THE PROPORTION OF NORMAL / BALANCED EMBRYOS Robertsonian Reciprocal % 20 >20 - <50 50 Proportion of normal / balanced embryos VISION /96-life
52 PREGNANCY RATE IN RELATION TO THE PROPORTION OF NORMAL / BALANCED EMBRYOS The pregnancy after PGD in traslocation carriers is proportional to the % of normal / balanced embryos. The analysis of gametes could have a prognostic value on the chances of pregnancy after PGD Sperm analysis on male carriers Preliminary exam for PGD cycle VISION /96-life
53 Società Italiana di Studi di Medicina della Riproduzione Analisi citogenetica per la traslocazione 46 XY t(14;20)(p11.2;q11.2) su cellule germinali maschili tramite F.I.S.H. (Fluorescence In Situ Hybridization) Sig. Data Data di nascita Campione di spermatozoi ottenuto ( ) per eiaculazione ( ) mediante recupero chirurgico dall apparato genitale in data e Accettazione in data N di cellule spermatiche analizzate: 107 N di cellule spermatiche diagnosticate: 107 (100 %) N di cellule spermatiche normali / bilanciate 81 (75,70 %) N di cellule spermatiche non bilanciate 26 (24,30 %) Utilizzate nel primo pannello le sonde specifiche per le regioni telomeriche 14q, 20p Utilizzate nel secondo pannello le sonde specifiche per le regioni centromeriche: 15 (controllo), 20 No. unbalanced sperm Diagnosi 14q 20p N spermatozoi (%) Normali (75,70) t(14;20) (p11.2;q11.2) Segregazione 2:2, adiacente I t(14;20) (p11.2;q11.2) Segregazione 2:2, adiacente II (17,76) (6,54) Totale 107
54
55 PGD FOR TRANSLOCATIONS INTERCHROMOSOMAL EFFECT Rob. Rec. P No. cycles Age No. diagnosed embryos FISH normal (%) 58 (24) 23 (14) FISH abnormal (%) 176 (76) 143 (88) for chromosomes transl. related (%) 43 (24) 67 (47) mixed (%) 64 (37) 37 (26) N.S. for chromosomes transl. non related (%) 46 (26) 23 (16) 0.05 haploidy/polyploidy (%) 23 (13) 16 (11) N.S. Modified from: Gianaroli L, Magli MC, Ferraretti AP, Munnè S, Balicchia B, Escudero T, Crippa A. (2002) Possible interchromosomal effect in embryos generated by gametes from translocation carriers. Hum Rep 17, VISION /96-life
56 PGD FOR ANEUPLOIDY Indication No. cycles No. FISH diagnosed embryos % FISH normal % clinical pregnancies % implantation Maternal age36 years Repeated cycles Gonosomal mosaicism Robertsonian translocations Reciprocal translocations Recurrent abortions Azoospermia Poor responders3 oocytes VISION
57 PGD FOR ANEUPLOIDY N patients 738 N cycles 1027 Age (M SD) N diagnosed embryos 5102 FISH normal (%) 1676 (33) FISH abnormal (%) 3426 (67) Monosomy trisomy (%) 1432 (42) N transferred cycles (%) 697 (68) N transferred embryos (M SD) 1.7±0.7 N clinical pregnancies (%) 203 (29) N spontaneous abortions (%) 35 (16) Implantation rate (%) 20.7 Implantation rate / pregnant patient (%) 65.2 Vision
58
59 % CHROMOSOMAL ABNORMALITIES AND CELLULAR STAGE a NORMAL KARYOTYPE n=4249 a b Number of cells at 62 hrs post insemination b c Number of embryos c a P<0.001 b P<0.001 c P<0.05 Vision
60 X Y VISION 2000
61 MALE CONTRIBUTION TO ANEUPLOIDY PGD for aneuploidy 201 patients 261 cycles 3 repeated IVF cycles (n=121) MESA-TESE > 1 IVF failure (n=52) No indications (n=88) X Y Maternal age35 yrs Normal karyotype Vision
62 % a P<0.025 bcd P<0.001 CHROMOSOMAL ANALYSIS ON SPERM CHROMOSOMALLY NORMAL SAMPLES a b c d a n=331 Normospermic OAT sev. OAT MESA TESE Modified from Gianaroli L, Magli MC, Ferraretti AP (2005) Sperm and blastomere aneuploidy detection in reproductive genetics and medicine. J. Histochem. Cytochem. b c d Vision
63 CHROMOSOMAL ANALYSIS ON SPERM INCIDENCE OF ANEUPLOIDY PER SINGLE CHROMOSOME n=331 % XY Modified from Gianaroli L, Magli MC, Ferraretti AP (2005) Sperm and blastomere aneuploidy detection in reproductive genetics and medicine. J. Histochem. Cytochem. Vision
64 % CHROMOSOMALLY ABNORMAL EMBRYOS CHAOTIC MOSAICS Normo Normo TMC TMC MESA TESE TESE IVF ICSI 0.5x10 6 <0.5x10 6 obstructive non-obstr. n=127 n=38 n=63 n=81 n=20 n=6 n=42 a P<0.001 a Vision
65 % CHROMOSOMALLY ABNORMAL EMBRYOS GONOSOMAL ANEUPLOIDY ab a b Normo Normo TMC TMC MESA TESE TESE IVF ICSI 0.5x10 6 <0.5x10 6 obstructive non-obstr. a P<0.025 Vision
66 PGD FOR ANEUPLOIDY Polar body Polar body and blastomere Blastomere No. cycles Age (MSD) Previous IVF cycles (MSD) No. oocytes No. 2PN biopsied FISH normal (%) 29 (27) 48 (20) - FISH abnormal (%) 69 (64) 114 (48) - No result (%) 10 (9) 76 (32) - No. biopsied embryos FISH normal (%) - 31 (46) 117 (31) FISH abnormal (%) - 36 (54) 258 (69) No result (%) No. embryos transferred No. cycles transferred (%) 13 (68) No. clinical pregnancies (%) 3 (23) 10 (35) 17 (36) Implantation rate (%) No. Abortions 0 1* 1 *ectopic VISION
67 ANEUPLOIDY PGD SINGLE GENE DISORDERS VISION 2000
68 I PB BIOPSY EMBRYO BIOPSY PROS -BY PRODUCT ANALYSIS -NO MOSAICISM RISK -NPP -FEMALE AND MALE GENETIC MATERIAL -REPETEABILITY OF THE TEST -IMPACT ON PREDICTION OF VIABILITY -SET IMPLEMENTED CONS -ONLY FEMALE GENETIC MATERIAL -SHORT AMOUNT OF TIME -SKILLED EMBRYOLOGISTS -PIF -RISK OF MISDIAGNOSIS -REDUCTION OF EMBRYONIC MASS
69 PATIENT SELECTION MATERNAL AGE 36 yrs 3 FAILED IVF CYCLES ALTERED KARYOTYPE TRANSLOCATION CARRIERS RECURRENT ABORTIONS MESA TESE POOR RESPONDERS TRANSFER IVF PGD + NO TRANSFER PGD FOR MONOGENIC DISEASES ADROLOGIST NO PREGNANCY PREGNANCY FISH ON SPERMATOZOA HIGH % FISH ABNORMAL TRANSFER NORMAL % FISH ABNORMALITIES DONOR SPERM FISH NORMAL PB BIOPSY OOCYTE DONATION 8 cells EMBRYO COLTURE FISH ABNORMAL NO TRANSFER
70 SHOULD WE TEST THE FIRST POLAR BODY OR THE EMBRYO L. Gianaroli, C.M. Magli, A.P. Ferraretti Reproductive Medicine Unit - Via Mazzini, Bologna sismer@sismer.it
71
72
73
74
75 -higher is the success rate of a routine program lower is the need for AS -higher is the incidence of difficult patients higher is the need for AS -higher is the interest to costumize the service higher is the need for AS
76
77
Articles Impact of parental gonosomal mosaicism detected in peripheral blood on preimplantation embryos
RBMOnline - Vol 5. No 3. 306 312 Reproductive BioMedicine Online; www.rbmonline.com/article/699 on web 12 September Articles Impact of parental gonosomal mosaicism detected in peripheral blood on preimplantation
More informationIncidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients
Incidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients M. C. MAGLI,1 L. GIANAROLI,1,3 S. MUNNE,2 and A. P. FERRARETTI1 Submitted: December 29,
More informationPreimplantation genetic diagnosis: polar body and embryo biopsy
Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director
More informationEmbryo morphology and development are dependent on the chromosomal complement
Embryo morphology and development are dependent on the chromosomal complement M. Cristina Magli, M.Sc., Luca Gianaroli, M.D., Anna Pia Ferraretti, M.D., Ph.D., Michela Lappi, B.Sc., Alessandra Ruberti,
More informationLuca Gianaroli, M.D.,* M. Cristina Magli, M.Sc.,* Anna P. Ferraretti, Ph.D.,* and Santiago Munné, Ph.D.
FERTILITY AND STERILITY VOL. 72, NO. 5, NOVEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Preimplantation diagnosis
More informationAbstract. Introduction
RBMOnline - Vol 13 No 6. 2006 869-874 Reproductive BioMedicine Online; www.rbmonline.com/article/2507 on web 18 October 2006 Article Preimplantation genetic diagnosis significantly improves the pregnancy
More informationS.Kahraman 1,4, M.Bahçe 2,H.Şamlı 3, N.İmirzalıoğlu 2, K.Yakısn 1, G.Cengiz 1 and E.Dönmez 1
Human Reproduction vol.15 no.9 pp.2003 2007, 2000 Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation
More informationPolar Body Approach to PGD. Anver KULIEV. Reproductive Genetics Institute
Polar Body Approach to PGD Anver KULIEV Reproductive Genetics Institute DISCLOSURE othing to disclose 14 History of Polar Body Approach 14 First proposed in World Health Organization s Document Perspectives
More informationIdentification of embryonic chromosomal abnormality using FISH-based preimplantaion genetic diagnosis
Ye et al. / J Zhejiang Univ SCI 2004 5(10):1249-1254 1249 Journal of Zhejiang University SCIENCE ISSN 1009-3095 http://www.zju.edu.cn/jzus E-mail: jzus@zju.edu.cn Identification of embryonic chromosomal
More informationBlastocentesis: innovation in embryo biopsy
Blastocentesis: innovation in embryo biopsy L. Gianaroli, MC Magli, A. Pomante, AP Ferraretti S.I.S.Me.R. Reproductive Medicine Unit, Bologna, Italy Bologna, 8-11 May 2016 www.iiarg.com www.sismer.it 2013
More informationIndications for chromosome screening Dagan Wells, PhD, FRCPath dagan.wells@obs-gyn.ox.ac.ukgyn.ox.ac.uk Chromosome imbalance (aneuploidy) Uncontroversial data The incidence of aneuploidy Aneuploidy is
More informationChromosomal Aneuploidy
The Many Advantages of Trophectoderm Biopsy Compared to Day 3 Biopsy for Pre- Implantation Genetic Screening (PGS) Mandy Katz-Jaffe, PhD Chromosomal Aneuploidy Trisomy 21 Fetus Aneuploidy is the most common
More informationArticle Impact of meiotic and mitotic non-disjunction on generation of human embryonic stem cell lines
RBMOn - Vol 18. No 1. 2009 120-126 Reproductive BioMedicine On; www.rbmon.com/article/3656 on web 21 November 2008 Article Impact of meiotic and mitotic non-disjunction on generation of human embryonic
More informationUnderstanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre
Understanding eggs, sperm and embryos Marta Jansa Perez Wolfson Fertility Centre What does embryology involve? Aims of the embryology laboratory Creation of a large number of embryos and supporting their
More informationAbstract. Introduction. RBMOnline - Vol 10. No Reproductive BioMedicine Online; on web 19 January 2005
RBMOnline - Vol 10. No 3. 2005 381-388 Reproductive BioMedicine Online; www.rbmonline.com/article/1593 on web 19 January 2005 Article Preimplantation genetic diagnosis for aneuploidy screening in repeated
More informationAbstract. Introduction. RBMOnline - Vol 11. No Reproductive BioMedicine Online; on web 11 August 2005
RBMOnline - Vol 11. No 4. 2005 497 506 Reproductive BioMedicine Online; www.rbmonline.com/article/1712 on web 11 August 2005 Article FISH screening of aneuploidies in preimplantation embryos to improve
More informationASSISTED REPRODUCTIVE TECHNOLOGIES (ART)
ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) Dr. Herve Lucas, MD, PhD, Biologist, Andrologist Dr. Taher Elbarbary, MD Gynecologist-Obstetrician Geneva Foundation for Medical Education and research Definitions
More informationPre-implantation genetic diagnosis in Hong Kong. Ng, EHY; Lau, EYL; Yeung, WSB; Lau, ETK; Tang, MHY; Ho, PC
Title Pre-implantation genetic diagnosis in Hong Kong Author(s) Ng, EHY; Lau, EYL; Yeung, WSB; Lau, ETK; Tang, MHY; Ho, PC Citation Hong Kong Medical Journal, 2003, v. 9 n. 1, p. 43-47 Issued Date 2003
More informationEffect of chromosomal translocations on the development of preimplantation human embryos in vitro
FERTILITY AND STERILITY VOL. 74, NO. 4, OCTOBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A.,2 Effect of chromosomal
More informationPolar body array CGH for prediction of the status of the corresponding oocyte. Part II: technical aspects
Human Reproduction, Vol.26, No.11 pp. 3181 3185, 2011 Advanced Access publication on September 9, 2011 doi:10.1093/humrep/der295 TECHNICAL NOTE Reproductive genetics Polar body array CGH for prediction
More informationPreimplantation Genetic Testing
Protocol Preimplantation Genetic Testing (40205) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization No Review Dates: 09/11, 09/12, 09/13 The following Protocol contains medical
More informationPronuclear morphology evaluation for fresh in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) cycles: a systematic review
Nicoli et al. Journal of Ovarian Research 2013, 6:64 REVIEW Open Access Pronuclear morphology evaluation for fresh in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) cycles: a systematic
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More informationArticle Negligible interchromosomal effect in embryos of Robertsonian translocation carriers
RBMOnline - Vol 10. No 3. 2005 363-369 Reproductive BioMedicine Online; www.rbmonline.com/article/1630 on web 17 January 2005 Article Negligible interchromosomal effect in embryos of Robertsonian translocation
More informationArticle Preimplantation genetic diagnosis of numerical abnormalities for 13 chromosomes
RBMOnline - Vol 6. No 2. 226 231 Reproductive BioMedicine Online; www.rbmonline.com/article/794 on web 28 January 2003 Article Preimplantation genetic diagnosis of numerical abnormalities for 13 chromosomes
More informationBlastocyst Morphology Holds Clues Concerning The Chromosomal Status of The Embryo
Original Article Blastocyst Morphology Holds Clues Concerning The Chromosomal Status of The Embryo Rita de Cassia Savio Figueira, M.Sc. 1, Amanda Souza Setti, B.Sc. 1,, Daniela Paes Almeida Ferreira Braga,
More informationProblem Challenge Need. Solution Innovation Invention
Problem Challenge Need Solution Innovation Invention Tubal Infertility In-vitro Fertilisation Steptoe and Edwards Birth after the reimplantation of a human embryo. Lancet 1978 Louise Brown, 25. Juli 1978
More informationUNDERSTANDING THE GENETIC HEALTH OF EMBRYOS
UNDERSTANDING THE GENETIC HEALTH OF EMBRYOS What is preimplantation genetic testing for aneuploidy? (an abnormal number of chromosomes; PGT-A) is a testing technique that can help choose embryos that appear
More informationUSA: Livingston, NJ. PGD for infertility. Europe: Barcelona, Spain Oxford, UK Hamburg, Germany. Asia: Kobe, Japan. South America: Lima, Peru
PGD for infertility Santiago Munné USA: Livingston, NJ Europe: Barcelona, Spain Oxford, UK Hamburg, Germany Asia: Kobe, Japan South America: Lima, Peru The majority of embryos with good morphology are
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationPreimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo?
DOI 10.1007/s10815-011-9608-7 GENETICS Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo? Kim Dao Ly & Ashok Agarwal & Zsolt Peter Nagy Received:
More informationEmbryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities*
FERTILITY AND STERILITY Copyright {j 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Embryo morphology, developmental rates, and maternal age are correlated with
More informationComparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement
Comparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement Wei-Hua Wang, Ph.D., Khalied Kaskar, M.S., Yuhong Ren, M.S., Jimmy Gill, M.D.,
More informationComprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study
ORIGINAL ARTICLES: ASSISTED REPRODUCTION Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study Richard T. Scott
More informationPreimplantation Genetic Testing Where are we going? Genomics Clinical Medicine Symposium Sept 29,2012 Jason Flanagan, MS,CGC
Preimplantation Genetic Testing Where are we going? Genomics Clinical Medicine Symposium Sept 29,2012 Jason Flanagan, MS,CGC Overview Discuss what PGD and PGS are Pt examples What we have learned Where
More informationChromosome Abnormalities
Chromosome Abnormalities Chromosomal abnormalities vs. molecular mutations Simply a matter of size Chromosomal abnormalities are big errors Two types of abnormalities 1. Constitutional problem present
More informationArticle Pre-embryonic diagnosis for Sandhoff disease
RBMOnline - Vol 12. No 3. 2006 328-333 Reproductive BioMedicine Online; www.rbmonline.com/article/2100 on web 9 January 2006 Article Pre-embryonic diagnosis for Sandhoff disease Dr Anver Kuliev received
More informationIMPACT OF SPERM QUALITY ON
IMPACT OF SPERM QUALITY ON EMBRYO VIABILITY M.C. Magli, L. Gianaroli, A.P. Ferraretti SISMER, Reproductive Medicine Unit, Bologna, Italy www.iiarg.com www.sismer.it LEARNING OBJECTIVES To define the sperm
More informationUvA-DARE (Digital Academic Repository) Preimplantation genetic screening: a reappraisal Mastenbroek, S. Link to publication
UvA-DARE (Digital Academic Repository) Preimplantation genetic screening: a reappraisal Mastenbroek, S. Link to publication Citation for published version (APA): Mastenbroek, S. (2011). Preimplantation
More informationAn Update on PGD: Where we are today
An Update on PGD: Where we are today Joyce Harper UCL Centre for PG&D and CRGH Institute for Womens Health University College London Overview What is PGD/PGS How we do it Disadvantages and advantages Future
More informationReview Chromosome abnormalities and their relationship to morphology and development of human embryos
RBMOnline - Vol 12. No 2. 2006 234-253 Reproductive BioMedicine Online; www.rbmonline.com/article/2051 on web 14 December 2005 Review Chromosome abnormalities and their relationship to morphology and development
More informationPreimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent
Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent PGT analysis is offered to patients that seek to identify a chromosomal abnormality in their embryos prior to initiating
More informationAccuracy of FISH analysis in predicting chromosomal status in patients undergoing preimplantation genetic diagnosis
Accuracy of FISH analysis in predicting chromosomal status in patients undergoing preimplantation genetic diagnosis Catherine M. DeUgarte, M.D., a Man Li, M.D., Ph.D., b Mark Surrey, M.D., c Hal Danzer,
More informationPregnancy outcomes following 24-chromosome preimplantation genetic diagnosis in couples with balanced reciprocal or Robertsonian translocations
Pregnancy outcomes following 24-chromosome preimplantation genetic diagnosis in couples with balanced reciprocal or Robertsonian translocations Dennis Idowu, M.D., a Katrina Merrion, M.S., b Nina Wemmer,
More informationNew methods for embryo selection: NGS and MitoGrade
New methods for embryo selection: NGS and MitoGrade Santiago Munné, PhD US: Livingston, Los Angeles, Chicago, Portland, Miami / Europe: Barcelona (Spain), Oxford (UK), Hamburg (Germany) / Asia: Kobe (Japan),
More informationThe work of a fertility specialist Steven Fleming PhD Honorary Associate, University of Sydney Director of Embryology, ORIGIO a/s
The work of a fertility specialist Steven Fleming PhD Honorary Associate, University of Sydney Director of Embryology, ORIGIO a/s sfleming@origio.com Scope of work Evaluation and diagnosis of the infertile
More informationAbstract. Introduction. RBMOnline - Vol 8. No Reproductive BioMedicine Online; on web 19 April 2004
RBMOnline - Vol 8. No 6. 2004 695-700 Reproductive BioMedicine Online; www.rbmonline.com/article/1296 on web 19 April 2004 Article Pronuclear morphology predicts embryo development and chromosome constitution
More informationOrganisation of the PGD Centre. Overview. Setting up a PGD centre
Organisation of the PGD Centre Joyce Harper Chair of the ESHRE PGD Consortium Overview Setting up a PGD Centre Organisation of the PGD Centre Preparation for clinical PGD Misdiagnosis Accreditation External
More informationPREIMPLANTATION GENETIC DIAGNOSIS
PREIMPLANTATION GENETIC DIAGNOSIS Peter Braude, Susan Pickering, Frances Flinter and Caroline Mackie Ogilvie Preimplantation genetic diagnosis (PGD) is an evolving technique that provides a practical alternative
More informationC H A P T E R Molecular Genetics Techniques for Preimplantation Genetic Diagnosis
Author, please provide citation of references 82, 83 in the text C H A P T E R Molecular Genetics 16 Techniques for Preimplantation Genetic Diagnosis Francesco Fiorentino, Gayle M Jones Introduction HISTORICAL
More informationAneuploidies: the embryo point of view
Aneuploidies: the embryo point of view MC Magli, A. Pomante, AP Ferraretti, L. Gianaroli S.I.S.Me.. eproductive Medicine Unit, Bologna, Italy www.iiarg.com www.sismer.it Bologna, May 8-11, 2016 1 46 chromosomes?????
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationArticle Which patients with recurrent implantation failure after IVF benefit from PGD for aneuploidy screening?
RBMOnline - Vol 12. No 3. 2006 334-339 Reproductive BioMedicine Online; www.rbmonline.com/article/1947 on web 25 January 2006 Article Which patients with recurrent implantation failure after IVF benefit
More informationDiagnostic Techniques to Improve the Assessment of Human IVF Embryos: Genomics and Proteomics
Diagnostic Techniques to Improve the Assessment of Human IVF Embryos: Genomics and Proteomics Mandy G Katz-Jaffe Introduction A fundamental component of assisted reproductive technologies (ART) is the
More informationETHICAL ISSUES IN REPRODUCTIVE MEDICINE
ETHICAL ISSUES IN REPRODUCTIVE MEDICINE Medicine was, in its history, first of all curative, then preventive and finally predictive, whereas today the order is reversed: initially predictive, then preventive
More informationArticle Screening oocytes by polar body biopsy
RBMOnline - Vol 13. No 1. 2006 104 109 Reproductive BioMedicine Online; www.rbmonline.com/article/2181 on web 15 March 2005 Article Screening oocytes by polar body biopsy Dr Anja Dawson graduated from
More informationOriginal Policy Date
MP 2.04.77 Preimplantation Genetic Testing Medical Policy Section OB/Gyn/Reproduction Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to
More informationIncrease your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0)
Increase your chance of IVF Success PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0) What is PGT-A? PGT-A, or Preimplantation Genetic Testing for Aneuploidy (PGS 2.0), is a type of genomic
More informationEuropean IVF Monitoring (EIM) Year: 2013
European IVF Monitoring (EIM) Year: 2013 Name of the country Poland Name and full address of the contact person. Anna Janicka, PhD Polish Society of Reproductive Medicine and Embryology Fertility and Sterility
More informationESHRE PGD Consortium data collection XIII: cycles from January to December 2010 with pregnancy follow-up to October 2011
Human Reproduction, Vol.30, No.8 pp. 1763 1789, 2015 Advanced Access publication on June 12, 2015 doi:10.1093/humrep/dev122 ESHRE PAGES ESHRE PGD Consortium data collection XIII: cycles from January to
More informationReproductive Technology, Genetic Testing, and Gene Therapy
Michael Cummings Chapter 16 Reproductive Technology, Genetic Testing, and Gene Therapy David Reisman University of South Carolina 16.1 Infertility Is a Common Problem In the US, about 13% of all couples
More informationValidation of Next-Generation Sequencer for 24-Chromosome Aneuploidy Screening in Human Embryos
GENETIC TESTING AND MOLECULAR BIOMARKERS Volume 21, Number 11, 2017 ª Mary Ann Liebert, Inc. Pp. 1 7 DOI: 10.1089/gtmb.2017.0108 ORIGINAL ARTICLE Validation of Next-Generation Sequencer for 24-Chromosome
More informationPre-implantation genetic diagnosis and pre-implantation genetic screening: two years experience at a single center
Original Article Obstet Gynecol Sci 2018;61(1):95-101 https://doi.org/10.5468/ogs.2018.61.1.95 pissn 2287-8572 eissn 2287-8580 Pre-implantation genetic diagnosis and pre-implantation genetic screening:
More informationINSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018
INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018 IVF-THE ULTIMATE GOAL FERTILISATION EMBRYO CLEAVAGE AND DEVELOPMENT POSITIVE HCG POSITIVE
More informationPreimplantation genetic diagnosis
Preimplantation genetic diagnosis Borut Peterlin Clinical institute of medical genetics, University Medical Centre Ljubljana Outline of the presentation Primary prevention of genetic diseases Motivation
More informationThe Impact of ESHRE 2017 on Japanese Fertility Practice
The Impact of ESHRE 2017 on Japanese Fertility Practice This resource is supported by an educational grant from Merck KGaA, Darmstadt, Germany. The GWHA was interested in the opinions of practicing clinicians
More informationSNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation carrier and normal blastocysts
J Assist Reprod Genet (2016) 33:1115 1119 DOI 10.1007/s10815-016-0734-0 TECHNOLOGICAL INNOVATIONS SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation
More informationCurrent value of preimplantation genetic aneuploidy screening in IVF
Human Reproduction Update, Vol.13, No.1 pp. 15 25, 2007 Advance Access publication September 7, 2006 doi:10.1093/humupd/dml043 Current value of preimplantation genetic aneuploidy screening in IVF P.Donoso
More informationClinical application of comprehensive chromosomal screening at the blastocyst stage
Clinical application of comprehensive chromosomal screening at the blastocyst stage William B. Schoolcraft, M.D., a Elpida Fragouli, Ph.D., b,c John Stevens, M.S., a Santiago Munne, Ph.D., d Mandy G. Katz-Jaffe,
More informationArticle Preimplantation diagnosis and HLA typing for haemoglobin disorders
RBMOnline - Vol 11. No 3. 2005 362-370 Reproductive BioMedicine Online; www.rbmonline.com/article/1853 on web 20 July 2005 Article Preimplantation diagnosis and HLA typing for haemoglobin disorders Dr
More informationPGS & PGD. Preimplantation Genetic Screening Preimplantation Genetic Diagnosis
1 PGS & PGD Preimplantation Genetic Screening Preimplantation Genetic Diagnosis OUR MISSION OUR MISSION CooperGenomics unites pioneering leaders in reproductive genetics, Reprogenetics, Recombine, and
More informationbut it still needs a bit of work
but it still needs a bit of work jc@embryos.net Reprogenetics ART Institute of Washington Life Global Principle investigator of cytoplasmic transfer series (1996-2001) Is there an alternative to MRT? Lessons
More informationRole of Preimplantation Genetic Diagnosis (PGD) in Current Infertility Practice
IJIFM REVIEW ARTICLE Role of Preimplantation Genetic Diagnosis (PGD) in Current Infertility Practice Role of Preimplantation Genetic Diagnosis (PGD) in Current Infertility Practice Helen Ghislaine Tempest,
More informationAdoption and Foster Care
GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationMyths About Success Rates Do they truly reflect quality of care
Myths About Success Rates Do they truly reflect quality of care Barry Behr PhD., HCLD Professor and IVF Laboratory Director Division of Reproductive Endocrinology and Infertility Dept OB/GYN Stanford University
More informationPreimplantation diagnosis: a realistic option for assisted reproduction and genetic practice Anver Kuliev and Yury Verlinsky
Preimplantation diagnosis: a realistic option for assisted reproduction and genetic practice Anver Kuliev and Yury Verlinsky Purpose of review Preimplantation genetic diagnosis (PGD) allows genetically
More informationDr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management
Dr Guy Gudex Director Repromed 17:00-17:30 Recent Advances in Fertility Management Recent Advances in Fertility Management Practice Nurses Programme NZMA GP CME June 2018 Dr Guy Gudex ART in NZ -2014 ACART
More informationPre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN
Pre-Implantation Genetic Diagnosis Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Our Clinical Vignette A young couple in the mid-to-late twenties presents to your clinic to discuss having children. The
More informationHonorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.
Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive
More informationThe development of cytogenetically normal, abnormal and mosaic embryos: a theoretical model
Human Reproduction Update, Vol.10, No.1 pp. 79±94, 2004 DOI: 10.1093/humupd/dmh005 The development of cytogenetically normal, abnormal and mosaic embryos: a theoretical model Frans J.Los 1, Diane Van Opstal
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationRejuvenation of Gamete Cells; Past, Present and Future
Rejuvenation of Gamete Cells; Past, Present and Future Denny Sakkas PhD Scientific Director, Boston IVF Waltham, MA, USA Conflict of Interest I have no conflict of interest related to this presentation.
More informationOrganisation of the PGD Centre
Organisation of the PGD Centre Joyce Harper Chair of the ESHRE PGD Consortium Overview Setting up a PGD Centre Organisation of the PGD Centre The patient Workup PGD cycle Misdiagnosis Accreditation EQA
More informationCYTOGENETICS Dr. Mary Ann Perle
CYTOGENETICS Dr. Mary Ann Perle I) Mitosis and metaphase chromosomes A) Chromosomes are most fully condensed and clearly distinguishable during mitosis. B) Mitosis (M phase) takes 1 to 2 hrs and is divided
More informationFERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida
FERTILITY PRESERVATION Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida 1 2 3 4 Oocyte Cryopreservation Experimental option Offer to single cancer
More informationEuropean IVF Monitoring (EIM) Year: 2012
European IVF Monitoring (EIM) Year: 2012 Name of the country Poland Name and full address of the contact person. Professor Rafal Kurzawa, MD PhD Wojska Polskiego 103 Street 70-483 Szczecin Poland Telephone
More informationComprehensive molecular cytogenetic analysis of the human blastocyst stage
Human Reproduction Vol.23, No.11 pp. 2596 2608, 2008 Advance Access publication on July 29, 2008 doi:10.1093/humrep/den287 Comprehensive molecular cytogenetic analysis of the human blastocyst stage E.
More informationArticle Non-informative results and monosomies in PGD: the importance of a third round of re-hybridization
RBMOnline - Vol 19. No 4. 2009 539 546 Reproductive BioMedicine Online; www.rbmonline.com/article/4053 on web 12 August 2009 Article Non-informative results and monosomies in PGD: the importance of a third
More informationA Stepwise Approach to Embryo Selection and Implantation Success
Precise Genetic Carrier Screening An Overview A Stepwise Approach to Embryo Selection and Implantation Success Put today s most advanced genetic screening technology to work for you and your family s future.
More informationHold On To Your Dreams
Hold On To Your Dreams Dr. Michael Kettel Dr. Sandy Chuan 1. THE BASICS OF IVF & EMBRYO DEVELOPMENT 2. IVF ADD-ONS - MYTH VS. SCIENCE IN VITRO FERTILIZATION 1. Ovarian Stimulation 2. Egg Retrieval 3. Create
More informationPre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN
Pre-Implantation Genetic Diagnosis Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Our Clinical Vignette A young couple in the mid-to-late twenties presents to your clinic to discuss having children. The
More informationPreimplantation genetic diagnosis (PGD) improves pregnancy outcome for translocation carriers with a history of recurrent losses
RECURRENT PREGNANCY LOSS Preimplantation genetic diagnosis (PGD) improves pregnancy outcome for translocation carriers with a history of recurrent losses Jill Fischer, M.S., Pere Colls, Ph.D., Tomas Escudero,
More informationCLINICAL RESULTS 2016
CLINICAL RESULTS 2016 RESULTS OF ASSISTED REPRODUCTIVE TREATMENTS CARRIED OUT ATTHEIVIGROUPDURING2016 In Vitro Fertilisation (IVF-ICSI) Ovum Donation (OVODON) Frozen Embryo Transfer PreimplantationGeneticDiagnosis
More informationWe can give you the very best chance of having a baby.
We can give you the very best chance of having a baby www.ivf-iscare.com ISCARE was founded in 1994 as a first private clinic specialized in reproductive medicine in the Czech Republic. This centre of
More informationApplication of OMICS technologies on Gamete and Embryo Selection
Application of OMICS technologies on Gamete and Embryo Selection Denny Sakkas, Ph.D. Scientific Director, Boston IVF Waltham, MA, USA THE FUTURE ROLE OF THE EMBRYOLOGIST WILL FOCUS ON PROVIDING OUR PATIENTS
More informationAbstract. Introduction. RBMOnline - Vol 8. No Reproductive BioMedicine Online; on web 22 December 2003
RBMOnline - Vol 8. No 2. 196-206 Reproductive BioMedicine Online; www.rbmonline.com/article/1113 on web 22 December 2003 Article Assessment of DNA fragmentation and aneuploidy on poor quality human embryos
More informationScientific and Clinical Advances Advisory Committee Paper
Scientific and Clinical Advances Advisory Committee Paper Paper title Paper number SCAAC(06/15)07 Meeting date 10 June 2015 Agenda item 7 Author Information/decision Resource implications Implementation
More information